What will this mean for DePuy-Synthes?
Johnson & Johnson will acquire surgical robotics company Auris Health (Bloomberg)
Johnson & Johnson has agreed to buy surgical robotics company Auris Health Inc. for about $3.4 billion in cash, in a deal that would give the drug giant a lung-cancer diagnostic and treatment tool.
Under the terms of the deal, announced Wednesday, J&J could also make additional payments of up to $2.35 billion to Auris based on milestones, the people said. Auris, a closely held firm led by industry veteran Fred Moll, has developed robotic surgi...
